References
- Bradford M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical Biochemistry 1976; 72: 248–254
- Hanzlik R. P., Wiley R. A., Gillesse T. J. Synthesis of tritiated bromobenzene derivatives. Journal of Labelled Compounds and Radiopharmaceuticals 1979; 15: 531–535
- Hanzlik R. P., Hogberg K., Judson C. M. Microsomal hydroxylation of specifically deuterated monosubstituted benzenes. Evidence for direct aromatic hydroxylation. Biochemistry 1984; 23: 3048–3055
- Hesse S., Mezger M., Wolff T. Activation of ‘14C’-chlorobiphenyls to protein-binding metabolites, by rat liver microsomes. Chemico-Biological Interactions 1978; 20: 355–365
- Hesse S., Mezger M. Involvement of phenolic metabolites in the irreversible protein-binding of aromatic hydrocarbons: Reactive metabolites of ‘14C’ naphthalene and ‘14C’-1-naphthol formed by rat liver microsomes. Molecular Pharmacology 1979; 16: 667–675
- Hesse S., Wolff T., Mezger M. Involvement of phenolic metabolites in the irreversible protein-binding of 14C-bromobenzene catalyzed by rat liver microsomes. Archives of Toxicology 1980, Supplement 4: 358–362
- Jollow D. J., Mitchell J. R., Zampaglione N., Gillette J. R. Bromobenzene-induced liver necrosis. Protective role of glutathione and evidence for 3,4-bromobenzene oxide as the hepatotoxic metabolite. Pharmacology 1974; 11: 151–169, (1974)
- Lau S. S., Zannoni V. G. Bromobenzene epoxidation leading to binding on macromolecular protein sites. Journal of Pharmacology and Experimental Therapeutics 1981; 219: 563–572
- Lau S. S., Monks T. J., Gillette J. R. Multiple reactive metabolites derived from bromobenzene. Drug Metabolism and Disposition 1984a; 12: 291–296
- Lau S. S., Monks T. J., Gillette J. R. Identification of 2-bromohydroquinone as a metabolite of bromobenzene and o-bromophenol: implications for bromobenzene-induced nephrotoxicity. The Journal of Pharmacology and Experimental Therapeutics 1984b; 230: 360–366
- Lau S. S., Monks T. J., Greene L. E., Gillette J. R. Detection and half-life of bromobenzene-3,4-oxide in blood. Xenobiotics 1984c; 14: 539–543
- Loosemore A., Light D. R., Walsh C. Studies on the autoinactivation behavior of pure, reconstituted phenobarbital-induced cytochrome P-450 isozyme from rat liver. Journal of Biological Chemistry 1980; 255: 9017–9020
- Lowry O. H., Rosebrough N. J., Farr L., Randall R. J. Protein measurement with the folin phenol reagent. Journal of Biological Chemistry 1951; 193: 265–275
- McMahon R. E., Culp H. W., Mills J., Marshall F. J. Demethylation studies. IV. The in vitro and in vivo cleavage of alkyl- and arylalkyl-p-nitrophenyl ethers. Journal of Medicinal Chemistry 1963; 6: 343–346
- Monks T. J., Hinson J. A., Gillette J. R. Bromobenzene and p–bromophenol toxicity and covalent binding in vivo. Life Sciences 1982; 30: 841–848
- Reid W. D., Christie B., Krishna G., Mitchell J. R., Moskowitz J., Brodie B. B. Bromobenzene metabolism and hepatic necrosis. Pharmacology 1971; 6: 41–55
- Reid W. D., Krishna G. Centrolobular hepatic necrosis related to covalent binding of metabolites of halogenattd aromatic hydrocarbons. Experimental and Molecular Pathology 1973; 18: 90–99
- Sipes G., Krishna G., Brodie B. B. Mechanism of bromobenzene toxicity. II. Studies in vitro. Federation Proceedings 1971; 30: 439
- Tunek A., Platt K. L., Bentley P., Oesch F. Microsomal metabolism of benzene to species irreversibly binding to microsomal protein and effects of modifications of this metabolism. Molecular Pharmacology 1978; 14: 920–929